Have a personal or library account? Click to login
Influence of surgical treatment and radiotherapy of the advanced intraoral cancers on complete blood count, body mass index, liver enzymes and leukocyte CD64 expression Cover

Influence of surgical treatment and radiotherapy of the advanced intraoral cancers on complete blood count, body mass index, liver enzymes and leukocyte CD64 expression

Open Access
|Oct 2009

References

  1. Black RJ, Bray F, Ferlay J, Parkin DM. Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990. Eur J Cancer 1997; 33: 1075-107.10.1016/S0959-8049(96)00492-3
  2. Forastiere A, Koch W, Trotti A, Sidransky D. Head and Neck Cancer. N Engl J Med 2001; 345: 1890-900.10.1056/NEJMra001375
  3. Rogers SN, Brown JS, Woolgar JA, Lowe D, Magennis P, Shaw RJ, et al. Survival following primary surgery for oral cancer. Oral Oncol 2009; 45: 201-11.10.1016/j.oraloncology.2008.05.008
  4. Samardziski M, Zafiroski G, Tolevska C, Kalicanin-Markovska M, Doncovska D, Anevska V, et al. Treatment of patients with "high grade" extremity localized chondrosarcoma. Preliminary results. Radiol Oncol 2009; 43: 187-94.
  5. Kovač V, Smrdel U. Meta-analyses of clinical trials in patients with non-small cell lung cancer. Neoplasma 2004; 51: 334-40
  6. Oblak I. Anderluh F, Velenik V. Postoperative radiochemotherapy for gastric adenocarcinoma: long term results. Radiol Oncol 2009; 43: 274-81.
  7. Shah JP. Patterns of cervical lymph node metastasis from squamous carcinomas of the upper aerodigestive tract. Am J Surg 1990; 160: 405-9.10.1016/S0002-9610(05)80554-9
  8. Shah JP, Candela FC, Poddar AK. The patterns of cervical lymph node metastases from squamous carcinoma of the oral cavity. Cancer 1990; 66: 109-13.10.1002/1097-0142(19900701)66:1<;109::AID-CNCR2820660120>3.0.CO;2-A
  9. Shah JP, Andersen PE. The impact of patterns of nodal metastasis on modifications of neck dissection. Ann Surg Oncol 1994; 1: 521-32.10.1007/BF02303619
  10. Hashibe M, Ritz B, Le AD, Li G, Sankaranarayanan R, Zhang ZF. Radiotherapy for oral cancer as a risk factor for second primary cancers. Cancer Lett 2005; 220: 185-95.10.1016/j.canlet.2004.10.023
  11. Ni Choileain N, Redmond HP. Cell response to surgery. Arch Surg 2006; 141: 1132-40.10.1001/archsurg.141.11.1132
  12. Faist E, Schinkel C, Zimmer S. Update on the mechanisms of immune suppression of injury and immune modulation. World J Surg 1996; 20: 454-9.10.1007/s002689900071
  13. Weese JL, Ottery FD, Emoto SE. Do operations facilitate tumor growth? An experimental model in rats. Surgery 1986; 100: 273-7.
  14. Sietses C, Beelen RH, Meijer S, Cuesta MA. Immunological consequences of laparoscopic surgery, speculations on the cause and clinical implications. Langenbecks Arch Surg 1999; 384: 250-8.10.1007/s004230050200
  15. Carter JJ, Whelan RL. The immunologic consequences of laparoscopy in oncology. Surg Oncol Clin N Am 2001; 10: 655-77.10.1016/S1055-3207(18)30056-5
  16. Stavrev P, Schinkel C, Stavreva N, Fallone BG. How well are clinical gross tumor volume DVHs approximated by an analytical function? Radiol Oncol 2009; 43: 132-5.10.2478/v10019-009-0016-x
  17. Hellman S. Principles of cancer management: radiation therapy. In: De Vita Jr. VT, Hellman S, Rosenberg SA, editors. Cancer principles and practice of oncology. 5th Edit. New York: Lippincot-Raven; 1997. p. 303-33.
  18. Purdy JA, Klein EE. Photon external beam dosimetry and treatment planning. In: Perez CA, Brady LW, Halperin EC, editors. Principles and Practice of Radiation Oncology. Philadelphia: Lippincot Williams&Wilkins; 2008. p. 166-89.
  19. Amdur RJ, Parsons JT, Mendenhall WM, Million RR, Stringer SP, Cassisi NJ. Postoperative irradiation for squamous cell carcinoma of the head and neck: an analysis of treatment results and complications. Int J Radiat Oncol Biol Phys 1989; 16: 25-36.10.1016/0360-3016(89)90006-0
  20. Popanda O, Ebbeler R, Twardella D, Helmbold I, Gotzes F, Schmezer P, et al. Radiation-induced DNA damage and repair in lymphocytes from breast cancer patients and their correlation with acute skin reactions to radiotherapy. Int J Radiat Oncol Biol Phys 2003; 55: 1216-25.10.1016/S0360-3016(02)04415-2
  21. Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, et al, editors. AJCC Cancer Staging Manual. 6th Edit. New York: Springer; 2002.10.1007/978-1-4757-3656-4
  22. Smeele LE, Irish J, Gullane PJ, Neligan P, Brown DH, Rotstein LE. A retrospective comparison of the morbidity and cost of different reconstructive strategies in oral andoropharyngeal carcinoma. Laryngoscope 1999; 109: 800-4.10.1097/00005537-199905000-00022
  23. Scott SN, Boeve TJ, McCulloch TM, Fitzpatrick KA, Karnell LH. The effects of epoetin alfa on transfusion requirements in head and neck cancer patients: a prospective, randomized, placebo-controlled study. Laryngoscope 2002; 112: 1221-9.10.1097/00005537-200207000-00015
  24. van de Pol SM, Doornaert PA, de Bree R, Leemans CR, Slotman BJ, Langendijk JA. The significance of anemia in squamous cell head and neck cancer treated with surgery and postoperative radiotherapy. Oral Oncol 2006; 42: 131-8.10.1016/j.oraloncology.2005.06.021
  25. Becker A, Stadler P, Lavey RS, Hänsgen G, Kuhnt T, Lautenschläger C, et al. Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys. 2000; 46: 459-66.10.1016/S0360-3016(99)00384-3
  26. van Acht MJ, Hermans J, Boks DE, Leer JWH. The prognostic value of hemoglobin and a decrease hemoglobin during radiotherapy in laryngeal carcinoma. Int J Radiat Oncol Biol Phys 1992; 23: 229-35.10.1016/S0167-8140(92)80126-4
  27. Lee WR, Berkey B, Marcial V, Fu KK, Cooper JS, Vikram B, et al. Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: a secondary analysis of RTOG 85-27. Int J Radiat Oncol Biol Phys 1998; 42: 1069-75.10.1016/S0360-3016(98)00348-4
  28. Gray LH, Conger AD, Ebert M, Hornsey S, Scott OC. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol 1953; 26: 638-48.10.1259/0007-1285-26-312-638
  29. Vaupel P, Kelleher D, Höckel M. Oxygenation status of malignant tumors: pathogenesis of hypoxia and significance for tumor therapy. Sem Oncol 2001; 28: 29-35.10.1016/S0093-7754(01)90210-6
  30. Brand A, Houbiers JGA. Clinical studies of blood transfusion and cancer. In: E.C. Vamvakas and M.A. Blajchman, editors. Immunomodulatory Effects of Blood Transfusion. AABB Press; 1999, 145-190.
  31. Johnson JT, Taylor FH, Thearle PB. Blood transfusion and outcome in stage III head and neck carcinoma. Arch Otolaryngol Head Neck Surg 1987; 113: 307-10.10.1001/archotol.1987.01860030083014
  32. Jones KR, Weissler MC. Blood transfusion and other risk factors for recurrence of cancer of the head and neck. Arch Otolaryngol Head Neck Surg 1990; 116: 304-9.10.1001/archotol.1990.01870030068011
  33. van de Pol SM, Doornaert PA, de Bree R, Leemans CR, Slotman BJ, Langendijk JA. The significance of anemia in squamous cell head and neck cancer treated with surgery and postoperative radiotherapy. Oral Oncol 2006; 42: 131-8.10.1016/j.oraloncology.2005.06.021
  34. Nguyen-Tan PF, Le QT, Quivey JM, Singer M, Terris DJ, Goffinet DR, et al. Treatment results and prognostic factors of advanced T3-4 laryngeal carcinoma: the university of California, San Francisco (UCSF) and Stanford university hospital (SUH) experience. Int J Radiat Oncol Biol Phys 2001; 50: 1172-80.10.1016/S0360-3016(01)01538-3
  35. Velenik V. Locally recurrent rectal cancer: treatment options. Radiol Oncol 2009; 43: 144-51.10.2478/v10019-009-0028-6
  36. Oblak I, Strojan P, Zakotnik B, Budihna M, Smid L. Hemoglobin as a factor influencing the outcome in inoperable oropharyngeal carcinoma treated by concomitant radiochemotherapy. Neoplasma 2003; 50: 452-8.
  37. Griesshammer M, Bangerter M, Sauer T, Wennauer R, Bergmann L, Heimpel H. Aetiology and clinical significance of thrombocytosis: analysis of 732 patients with an elevated platelet count. J Intern Med 1999; 245: 295-300.10.1046/j.1365-2796.1999.00452.x10205592
  38. Lu CC, Chang KW, Chou FC, Cheng CY, Liu CJ. Association of pretreatment thrombocytosis with disease progression and survival in oral squamous cell carcinoma. Oral Oncol 2007; 43: 283-8.10.1016/j.oraloncology.2006.03.01016920387
  39. Scully C. Immunological abnormalities in oral carcinoma and oral keratosis. J Maxillofac Surg 1982; 10:113-5.10.1016/S0301-0503(82)80021-0
  40. Khanna NN, Das SN, Khanna S. Serum immunoglobulins in squamous cell carcinoma of the oral cavity. J Surg Oncol 1982; 20: 46-8.10.1002/jso.2930200111
  41. Brivio F, Lissoni P, Tisi E, Erba L, Barni S, Tancini G, et al. Effects of a preoperative therapy with IL-2 on surgery induced lymphocytopenia in cancer patients. Oncology 1992; 49: 215-8.10.1159/000227041
  42. Brivio F, Lissoni P, Tisi E, Erba L, Barni S, Tancini G, et al. Effects of a preoperative therapy with interleukin-2 on surgery-induced lymphocytopenia in cancer patients. Oncology 1992; 49: 215-8.10.1159/000227041
  43. Hamid J, Bancewicz J, Brown R, Ward C, Irving MH, Ford WL. The significance of changes in blood lymphocyte populations following surgical operations. Clin Exp Immunol 1984; 56: 49-57.
  44. Kuss I, Hathaway B, Ferris RL, Gooding W, Whiteside TL: Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck. Clin Cancer Res 2004; 10: 3755-62.10.1158/1078-0432.CCR-04-0054
  45. Uh S, Lee SM, Kim HT, Chung Y, Kim YH, Park C, et al. The effect of radiation therapy on immune function in patients with squamous cell lung carcinoma. Chest 1994; 105: 132-7.10.1378/chest.105.1.132
  46. Lissoni P, Meregalli S, Bonetto E, Mancuso M, Brivio F, Colciago M, et al. Radiotherapy-induced lymphocytopenia: changes in total lymphocyte count and in lymphocyte subpopulations under pelvic irradiation in gynecologic neoplasms. J Biol Regul Homeost Agents 2005; 19: 153-8.
  47. Gray WC, Hasslinger BJ, Suter CM, Blanchard CL, Goldstein AL, Chretien PB. Suppression of cellular immunity by head and neck irradiation. Precipitating factors and reparative mechanisms in an experimental model. Arch Otolaryngol Head Neck Surg 1986; 112: 1185-90.10.1001/archotol.1986.03780110061008
  48. Verastegui EL, Morales RB, Barrera-Franco JL, Poitevin AC, Hadden J. Long-term immune dysfunction after radiotherapy to the head and neck area. Int Immunopharmacol 2003; 3: 1093-104.10.1016/S1567-5769(03)00013-4
  49. Ohzato H, Yoshizaki K, Nishimoto N, Ogata A, Tagoh H, Monden M, et al. Interleukin-6 as a new indicator of inflammatory status: detection of serum levels of interleukin-6 and C-reactive protein after surgery. Surgery 1992; 111: 201-9.
  50. Kallio R, Bloigu A, Surcel HM, Syrjälä H. C-reactive protein and erythrocyte sedimentation rate in differential diagnosis between infections and neoplastic fever in patients with solid tumours and lymphomas. Support Care Cancer 2001; 9: 124-8.10.1007/s005200000181
  51. Brigden ML. Clinical utility of the erythrocyte sedimentation rate. Am Fam Physician 1999; 60: 1443-50.
  52. Nozoe T, Saeki H, Sugimachi K. Significance of preoperative elevation of serum C-reactive protein as an indicator of prognosis in esophageal carcinoma. Am J Surg 2001; 182: 197-201.10.1016/S0002-9610(01)00684-5
  53. Nozoe T, Matsumata T, Kitamura M, Sugimachi K. Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer. Am J Surg 1998; 176: 335-8.10.1016/S0002-9610(98)00204-9
  54. Kodama J, Miyagi Y, Seki N, Tokumo K, Yoshinouchi M, Kobashi Y, et al. Serum C-reactive protein as a prognostic factor in patients with epithelial ovarian cancer. Eur J Obstet Gynecol Reprod Biol 1999; 82: 107-10.10.1016/S0301-2115(98)00227-9
  55. Khandavilli SD, Ceallaigh PO, Lloyd CJ, Whitaker R. Serum C-reactive protein as a prognostic indicator in patients with oral squamous cell carcinoma. Oral Oncol 2009; 45: 912-4.10.1016/j.oraloncology.2009.03.015
  56. Lewis, S.M. Erythrocyte sedimentation rate and plasma viscosity. Association of Clinical Pathologists. Broadsheet 94, June 1980.
  57. Hart GD, Soots M, Sullivan J. Significance of extreme elevation of erythrocyte sedimentation rate. Appl Ther 1970; 12: 12-3.
  58. Tang JT, Yamazaki H, Nishimoto N, Inoue T, Nose T, Koizumi M, et al. Effect of radiotherapy on serum level of interleukin 6 in patients with cervical carcinoma. Anticancer Res 1996; 16: 2005-8.
  59. Koc M, Taysi S, Sezen O, Bakan N. Levels of some acute-phase proteins in the serum of patients with cancer during radiotherapy. Biol Pharm Bull 2003; 26: 1494-7.10.1248/bpb.26.1494
  60. Cengiz M, Akbulut S, Atahan IL, Grigsby PW. Acute phase response during radiotherapy. Int J Radiat Oncol Biol Phys 2001; 49: 1093-6.10.1016/S0360-3016(00)01426-7
  61. Nimmerjahn F, Ravetch JV. Fcγ receptors: old friends and new family members. Immunity 2006; 24: 19-28.10.1016/j.immuni.2005.11.010
  62. Radaev S, Sun P. Recognition of immunoglobulins by Fcγ receptors. Molecular Immunology 2002; 38: 1073-83.10.1016/S0161-5890(02)00036-6
  63. Guyre PM, Campbell AS, Kniffin WD, Fanger MW. Monocytes and polymorphonuclear neutrophils of patients with streptococcal pharyngitis express increased numbers of type I IgG Fc receptors. J Clin Invest 1990; 86: 1892-6.10.1172/JCI1149213298232147695
  64. Herra CM, Keane CT, Whelan A. Increased expression of Fcgamma receptors on neutrophils and monocytes may reflect ongoing bacterial infection. J Med Microbiol 1996; 44: 135-40.10.1099/00222615-44-2-1358642575
  65. Leino L, Sorvajarvi K, Katajisto J, Laine M, Lilius EM, Pelliniemi TT, et al. Febrile infection changes the expression of IgG Fc receptors and complement receptors in human neutrophils in vivo. Clin Exp Immunol 1997; 107: 37-43.10.1046/j.1365-2249.1997.d01-899.x19045619010254
  66. Qureshi SS, Lewis SM, Gant VA, Treacher D, Davis BH, Brown KA. Increased distribution and expression of CD64 on blood polymorphonuclear cells from patients with the systemic inflammatory response syndrome (SIRS). Clin Exp Immunol 2001; 125: 258-65.10.1046/j.1365-2249.2001.01596.x190613411529918
  67. Groselj-Grenc M, Ihan A, Derganc M. Neutrophil and monocyte CD64 and CD163 expression in critically ill neonates and children with sepsis: comparison of fluorescence intensities and calculated indexes. Mediators Inflamm 2008; 2008: 2026-46.10.1155/2008/202646244238518604302
  68. Hiesmayr MJ, Spittler A, Lassnigg A, Berger R, Laufer G, Kocher A, et al. Alterations in the number of circulating leucocytes, phenotype of monocyte and cytokine production in patients undergoing cardiothoracic surgery. Clin Exp Immunol 1999; 115: 315-23.10.1046/j.1365-2249.1999.00801.x19051649933459
  69. Fjaertoft G, Håkansson LD, Pauksens K, Sisask G, Venge P. Neutrophil CD64 (FcgammaRI) expression is a specific marker of bacterial infection: a study on the kinetics and the impact of major surgery. Scand J Infect Dis 2007; 39: 525-35.10.1080/0036554060111369317577814
  70. Nieto A, Sánchez MJ, Martínez C, Castellsagué X, Quintana MJ, Bosch X, et al. Lifetime body mass index and risk of oral cavity and oropharyngeal cancer by smoking and drinking habits. Br J Cancer 2003; 89: 1667-71.10.1038/sj.bjc.6601347239439714583768
  71. Strojan P. Cysteine cathepsins and stefins in head and neck cancer: an update of clinical studies. Radiol Oncol 2008; 42: 69-81.10.2478/v10019-008-0006-4
  72. Jurdana M. Cancer cachexia-anorexia syndrome and skeletal muscle wasting. Radiol Oncol 2009; 43: 65-75.10.2478/v10019-009-0007-y
DOI: https://doi.org/10.2478/v10019-009-0034-8 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 282 - 292
Published on: Oct 26, 2009
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2009 Tadej Dovšak, Alojz Ihan, Vojislav Didanovič, Andrej Kansky, Nataša Hren, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.

Volume 43 (2009): Issue 4 (December 2009)